• 1. Which of the following statements is correct?*
  • 2. What statement is correct about the pathophysiology and treatment of hypertrophic cardiomyopathy?*
  • 3. According to the AHA/ACC 2024 guidelines for management of HCM, which is the recommended approach in patients with obstructive HCM and persistent symptoms despite treatment with betablockers?*
  • Please rate the extent to which this activity met the following objectives:

  • Learning Objectives
    Rows
  • Do you feel this activity was fair balanced and free of commercial bias?
  • This educational activity will result in a change in my role as a healthcare team member.
  • This educational activity will result in a change in my practice behavior.
  • Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:
  • Date
     - -
    2 digit month, 2 digit day, 4 digit year
  • Attestation to time spent on activity: AcademicCME designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™ or 1.0 CNE Contact Hour (Provider #P0491).

  • Please select your credit type from the below:*
  • Through an agreement between the American Medical Association and the Union Européenne des Médecins Spécialistes, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits® (ECMECs®). These credits will be recognized by all National Accreditation Authorities in Europe with which the UEMS has a signed agreement of recognition of credits.

  • Should be Empty: